Headline
Wire
Time (ET)
DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
04/14/2023* 08:30 EST Earnings Call Q4 2023 -- -- --
04/14/2023* -- Results Q4 2023 -- -0.77 --
12/21/2022 08:30 EST Earnings Call Q3 2023 -- -- --
12/21/2022 -- Results Q3 2023 -0.14 -0.31 55.49%
09/29/2022 08:30 EST Earnings Call Q2 2023 -- -- --
09/29/2022 -- Results Q2 2023 -0.63 -0.55 -13.87%
06/23/2022 08:30 EST Earnings Call Q1 2023 -- -- --
06/23/2022 -- Results Q1 2023 -0.60 -0.70 14.31%
*Estimated Date/Time

Earnings

Next Report Date 04/14/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 12/21/2022
Beat/Miss Upgrade
Return Since -39.18%
Last FQE 11/30/2022
Next FQE 02/28/2023

Profile

Edit
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.
URL https://www.riteaid.com
Investor Relations URL https://investors.riteaid.com/
HQ State/Province Pennsylvania
Sector Healthcare
Industry Pharmaceutical Retailers
Equity Style Small Cap/Value
Next Earnings Release Apr. 14, 2023 (est.)
Last Earnings Release Dec. 21, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Oct. 14, 1999

Dividends

Dividend Per Share (TTM) 0.00
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date Oct. 14, 1999
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Annual Total Returns Versus Peers

Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
5.10%
-76.09%
-64.05%
9.21%
2.33%
-7.20%
-77.26%
-33.53%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
2.96%
-1.02%
-10.53%
-3.67%
-11.03%
-29.33%
35.81%
-25.00%
-12.33%
31.19%
31.90%
-28.30%
-6.14%
18.69%
21.26%
-60.39%
70.49%
32.29%
-28.77%
-81.63%
470.4%
14.45%
-65.82%
-89.44%
22.75%
116.7%
29.77%
-58.82%
-17.86%
1.04K%
-40.74%
-49.87%
-25.26%
As of March 23, 2023.

Profile

Edit
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.
URL https://www.riteaid.com
Investor Relations URL https://investors.riteaid.com/
HQ State/Province Pennsylvania
Sector Healthcare
Industry Pharmaceutical Retailers
Equity Style Small Cap/Value
Next Earnings Release Apr. 14, 2023 (est.)
Last Earnings Release Dec. 21, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Oct. 14, 1999

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

No data available
Symbol Dollars Invested % Weight
     
     
     
     
     
     
     
     
     
     

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter RAD Tweets